The 9 analysts offering 12-month price forecasts for Insmed Inc have a median target of 50.00, with a high estimate of 57.00 and a low estimate of 37.00. The median estimate represents a +67.50% increase from the last price of 29.85.
The current consensus among 9 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.56
Reporting Date Feb 25
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.